Cargando…
Simulating the Fiscal Impact of Anti-Obesity Medications as an Obesity Reduction Strategy
While substantial public health investment in anti-smoking initiatives has had demonstrated benefits on health and fiscal outcomes, similar investment in reducing obesity has not been undertaken, despite the substantial burden obesity places on society. Anti-obesity medications (AOMs) are poorly pre...
Autores principales: | Kabiri, Mina, Sexton Ward, Alison, Ramasamy, Abhilasha, Kee, Rebecca, Ganguly, Rahul, Smolarz, Brian Gabriel, Zvenyach, Tracy, Baumgardner, James R., Goldman, Dana P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970686/ https://www.ncbi.nlm.nih.gov/pubmed/33511897 http://dx.doi.org/10.1177/0046958021990516 |
Ejemplares similares
-
The Societal Value of Broader Access to Antiobesity Medications
por: Kabiri, Mina, et al.
Publicado: (2019) -
Direct medical costs of obesity in the United States and the most populous states
por: Cawley, John, et al.
Publicado: (2021) -
Economic value of nonsurgical weight loss in adults with obesity
por: Ding, Yuchen, et al.
Publicado: (2021) -
Effects of sustained weight loss on outcomes associated with obesity comorbidities and healthcare resource utilization
por: Wood, G. Craig, et al.
Publicado: (2021) -
Effectiveness of Combining Antiobesity Medication With an Employer-Based Weight Management Program for Treatment of Obesity: A Randomized Clinical Trial
por: Pantalone, Kevin M., et al.
Publicado: (2021)